PRA Health Sciences (PRAH) Tops Q4 EPS by 4c, Offers FY Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
PRA Health Sciences, Inc. Reports Fourth Quarter and Full Year 2018 Results and Provides First Quarter and Full Year 2019 Guidance
February 27, 2019 5:20 PM ESTNet new business of $667.3 million in the fourth quarter; Net book-to-bill of 1.30$729.6 million of revenue in the fourth quarter; 11.2% growth at actual foreign exchange rates and 12.0% growth on a constant currency basisFourth quarter GAAP net income per diluted share of $1.07 and GAAP net income of $71.5 millionFourth quarter adjusted net income per diluted share was $1.31 per share and adjusted net income was $86.9 million
RALEIGH, N.C., Feb. 27, 2019 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (PRA or the Company) (NASDAQ: PRAH) today... More
